FUB-144

FUB-144
Legal status
Legal status
Identifiers
IUPAC name
  • [1-(4-Fluorobenzyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC23H24FNO
Molar mass349.449 g·mol−1
3D model (JSmol)
SMILES
  • Fc1ccc(cc1)Cn1cc(c2c1cccc2)C(=O)C1C(C1(C)C)(C)C
InChI
  • InChI=1S/C23H24FNO/c1-22(2)21(23(22,3)4)20(26)18-14-25(19-8-6-5-7-17(18)19)13-15-9-11-16(24)12-10-15/h5-12,14,21H,13H2,1-4H3
  • Key:UXOFEILQVZFLRH-UHFFFAOYSA-N

FUB-144 (also known as FUB-UR-144) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is an analogue of UR-144 and XLR-11 where the pentyl chain has been replaced with fluorobenzyl.

In the United States, FUB-144 became a Schedule I Controlled Substance in 2019.[2]

Sweden's public health agency suggested classifying FUB-144 as hazardous substance on March 24, 2015.[3]

See also

References

  1. ↑ "FUB-144". Southern Association of Forensic Scientists. Archived from the original on 27 September 2015. Retrieved 23 July 2015.
  2. ↑ "Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I". Federal Register.
  3. ↑ "Fler ämnen föreslås bli klassade som narkotika eller hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.